Moxifloxacin tablets (Moxifloxacini compressi).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 10
- Publication type:
- Article
Works matching IS 10109609 AND DT 2019 AND VI 33 AND IP 1
Results: 8
1
2
ENVIRONMENTAL ASPECTS OF GOOD MANUFACTURING PRACTICES: POINTS TO CONSIDER FOR MANUFACTURERS AND INSPECTORS IN THE PREVENTION OF ANTIMICROBIAL RESISTANCE.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 29
- Publication type:
- Article
3
ANNEXURE: EXAMPLES OF CONSIDERATIONS AND RECOMMENDED REMAINING SHELF LIFE OF PRODUCTS.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 27
- Publication type:
- Article
4
POLICY ON REMAINING SHELF LIFE OF MEDICAL PRODUCTS.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 22
- Publication type:
- Article
5
Moxifloxacin hydrochloride (Moxifloxacini hydrochloridum).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 14
- Publication type:
- Article
6
Towards a global competency framework for regulators of medical products.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 06
- Publication type:
- Article
7
The School of International Nonproprietary Names.
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 02
- By:
- Publication type:
- Article
8
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2019, v. 33, n. 1, p. 43
- Publication type:
- Article